| B55 | Hormonal contraception is associated with increased risk of cardiometabolic disease in women living with HIV | E-poster | Contraception |
| B57 | Retention on antiretroviral treatment (ART) six and 18 months after delivery in women living with HIV (WL-HIV), in Brazil, 2010-2017 | E-poster | Other sex- or gender-specific issues |
| B58 | Relationship of the haematological profile with the viral load and clinical staging of HIV infected children at the Obafemi Awolowo university teaching hospitals complex (OAUTHC), Ile-Ife, Osun state, Nigeria | E-poster | Diagnosis of HIV disease in paediatric and adolescent populations |
| B58 | Plasma IP-10 concentrations show no correlation with HIV infection in children attending hospitals in Blantyre and Mulanje, Malawi | E-poster | Diagnosis of HIV disease in paediatric and adolescent populations |
| B59 | No age-related difference in dolutegravir metabolic glucuronidation ratio in children between 3 months and 18 years old in the ODYSSEY trial | E-poster | Pharmacokinetics, pharmacodynamics, pharmacogenomics and therapeutic drug monitoring in paediatric and adolescent populations |
| B59 | Expected impact of malnutrition on first-line antiretroviral drug exposure in a global population of children in countries with highest child mortality: a quantitative modeling and simulation study | E-poster | Pharmacokinetics, pharmacodynamics, pharmacogenomics and therapeutic drug monitoring in paediatric and adolescent populations |
| B59 | Pharmacokinetics and safety of dispersible and immediate release FDC abacavir/dolutegravir/lamivudine in children with HIV weighing '¥14 kg: preliminary results from IMPAACT 2019 | E-poster | Pharmacokinetics, pharmacodynamics, pharmacogenomics and therapeutic drug monitoring in paediatric and adolescent populations |
| B59 | Pharmacokinetics, safety and acceptability of a single dose of abacavir/lamivudine/lopinavir/ritonavir (4-in-1) fixed-dose granule formulation in neonates: PETITE study | E-poster | Pharmacokinetics, pharmacodynamics, pharmacogenomics and therapeutic drug monitoring in paediatric and adolescent populations |
| B6 | Evaluation of new high-throughput platforms for the quantification of HIV-1 RNA in plasma to support scale-up of viral load testing in low- and middle-income countries | On-demand oral abstract session | Viral load and CD4 measurement |
| B6 | More frequent viral load testing, with point-of-care tests has no impact on viral suppression in postpartum HIV-positive women in a randomized controlled trial in 2 clinics in Johannesburg, South Africa | Oral abstract session with live Q&A | Viral load and CD4 measurement |